Track topics on Twitter Track topics that are important to you
ArcherDX Inc. (next-generation sequencing (NGS) gene fusion detection assays) raised $35mm through a Series A round co-led by Boulder Ventures (added a board member) and PBM Capital Group. New investo...
The capital comes after a year of record growth for the company and penetration into liquid biopsy, immune sequencing, and companion diagnostic (CDx) markets. The Read more...
Previous studies showed that ALK is often positive in epithelioid fibrous histiocytoma (EFH). Two cases of EFH with ALK gene fusions have been recorded. Our objective was to study a series of EFH to p...
ArcherDX, the NGS applications company, is developing and commercializing a novel approach to target enrichment chemistry. Next-generation sequencing technology based on Anchored ...
PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare investments.Â Led by Paul Manning, a successful entrepreneur, the PBM Capital Group partners...
We have published hundreds of ArcherDX, Inc. news stories on BioPortfolio along with dozens of ArcherDX, Inc. Clinical Trials and PubMed Articles about ArcherDX, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ArcherDX, Inc. Companies in our database. You can also find out about relevant ArcherDX, Inc. Drugs and Medications on this site too.
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...